Prestige News

Total 70
Number Thumbnail Title Author Date Votes Views
60 Prestige Biopharma Outlines Phase 2a Clinical Development Roadmap for Pancreatic Cancer Therapy PBP1510
김** | 2026.06.01 | Votes 0 | Views 3235
김** 2026.06.01 0 3235
59 Prestige Biopharma Expands Global Collaboration Opportunities for Pancreatic Cancer Therapy at ASCO 2026
김** | 2026.05.26 | Votes 0 | Views 3601
김** 2026.05.26 0 3601
58 Prestige Biopharma IDC Signs Joint Research Agreement for Antibody Therapeutic Development Targeting Cancer Cachexia
김** | 2026.05.19 | Votes 0 | Views 2968
김** 2026.05.19 0 2968
57 Prestige BioPharma IDC Successfully Attracts Investment for Co-Development Partner
we******** | 2026.05.13 | Votes 0 | Views 1956
we******** 2026.05.13 0 1956
56 IDC Expands Asset Value to Over 200 Billion KRW… "Accelerating Commercialization on the Back of Financial Stability"
we******** | 2026.05.11 | Votes 0 | Views 2037
we******** 2026.05.11 0 2037
55 BJFEZ Expands ‘Insight Trip’ Program to High School Students: “Discovering the Future On-Site”
we******** | 2026.04.29 | Votes 0 | Views 1460
we******** 2026.04.29 0 1460
54 Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform ‘IDC224’
김** | 2026.04.21 | Votes 0 | Views 2266
김** 2026.04.21 0 2266
53 BJFEZ Advances Open Innovation Campus for AI-Driven Drug Development
김** | 2026.04.13 | Votes 0 | Views 1556
김** 2026.04.13 0 1556
52 Prestige Biopharma's Avastin Biosimilar HD204 Nears Regulatory Approval and Commercialization
김** | 2026.03.24 | Votes 0 | Views 3516
김** 2026.03.24 0 3516
51 Prestige Biopharma IDC Signs Strategic Research Collaboration Agreement with Pusan National University Medical Research Institu
김** | 2026.02.25 | Votes 0 | Views 1536
김** 2026.02.25 0 1536